U.S. markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.26 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.14 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.04
    -1.53 (-2.86%)
     
  • Gold

    1,827.70
    -23.70 (-1.28%)
     
  • Silver

    24.83
    -0.97 (-3.77%)
     
  • EUR/USD

    1.2085
    -0.0071 (-0.58%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • GBP/USD

    1.3583
    -0.0108 (-0.79%)
     
  • USD/JPY

    103.8710
    +0.0550 (+0.05%)
     
  • BTC-USD

    37,191.46
    +173.17 (+0.47%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • FTSE 100

    6,735.71
    -66.25 (-0.97%)
     
  • Nikkei 225

    28,519.18
    -179.08 (-0.62%)
     

Global Injectable Drug Delivery Devices Pipeline Assessment Report 2020 - ResearchAndMarkets.com

·4 min read

The "Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.

"Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020". Injectable Drug Delivery Devices are defined as administration of a drug into patient's blood through a delivery device.

Scope

  • Extensive coverage of the Injectable Drug Delivery Devices under development

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

  • The report reviews the major players involved in the development of Injectable Drug Delivery Devices and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Identify and understand important and diverse types of Injectable Drug Delivery Devices under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Injectable Drug Delivery Overview

3 Products under Development

3.1 Injectable Drug Delivery - Pipeline Products by Stage of Development

3.2 Injectable Drug Delivery - Pipeline Products by Segment

3.3 Injectable Drug Delivery - Pipeline Products by Territory

3.4 Injectable Drug Delivery - Pipeline Products by Regulatory Path

3.5 Injectable Drug Delivery - Pipeline Products by Estimated Approval Date

3.6 Injectable Drug Delivery - Ongoing Clinical Trials

4 Injectable Drug Delivery - Pipeline Products under Development by Companies

4.1 Injectable Drug Delivery Companies - Pipeline Products by Stage of Development

4.2 Injectable Drug Delivery - Pipeline Products by Stage of Development

5 Injectable Drug Delivery Companies and Product Overview

6 Injectable Drug Delivery- Recent Developments 2137 Appendix

7 Appendix

Companies Mentioned

  • Adalvo

  • Adamis Pharmaceuticals Corp

  • AdrenaCard, Inc.

  • AktiVax Inc.

  • Allergan Ltd

  • Alsensa ApS

  • Antares Pharma Inc

  • Aquavit Pharmaceuticals Inc

  • Artemes Technologies, Inc.

  • Ascendis Pharma A/S

  • ASCIL Biopharm

  • ASIS Corp

  • AzureBio SL

  • Bespak Europe Ltd

  • Biocorp Production SA

  • 1BioCorRx Inc

  • BioRestorative Therapies Inc

  • Bioxis Pharmaceuticals

  • Brigham and Women's Hospital

  • Burke Pharmaceuticals LLC

  • Calla Health Foundation

  • Callisyn Biomedical Inc

  • Cambridge Consultants Ltd

  • Camurus AB

  • Case Western Reserve University

  • Cincinnati Children's Hospital Medical Center

  • Clearside BioMedical Inc

  • DALI Medical Devices Ltd.

  • DelSite, Inc. (Inactive)

  • Drexel University

  • Duoject Medical Systems Inc

  • Ecole Polytechnique Federale de Lausanne

  • Elcam Medical

  • EmboMedics Inc

  • Embryyo Technologies Pvt Ltd

  • Emergent BioSolutions Inc

  • EP Global Communications Inc (Inactive)

  • Eveon SAS

  • EyePoint Pharmaceuticals Inc

  • FHC Inc

  • GeneSYS-ID Inc

  • Georgia Institute of Technology

  • Ghent University

  • Globe Medical Tech Inc (Inactive)

  • Hoffmann-La Roche Inc

  • Inovio Pharmaceuticals Inc

  • InVivo Therapeutics Corp

  • Ionic Pharmaceuticals LLC

  • JCR Pharmaceuticals Co Ltd

  • komarik

  • Kyowa Kirin Ltd

  • Lohmann Therapie-Systeme AG

  • 5LyoGo

  • Mallinckrodt Plc

  • Mercator MedSystems Inc

  • Mertiva AB

  • Midas Pharma GmbH

  • Milestone Scientific Inc

  • 5Millendo Therapeutics Inc

  • Morimoto Pharma Co Ltd

  • NanoPass Technologies Ltd

  • Novo Nordisk AS

  • Novosanis NV

  • Osteo Pharma BV

  • Oval Medical Technologies Ltd

  • Owen Mumford Ltd

  • Palatin Technologies Inc

  • Particle Therapeutics Ltd

  • Portal Instruments Inc

  • Prohibix LLC

  • QuiO Technologies LLC

  • Regeneron Pharmaceuticals Inc

  • RepliCel Life Sciences Inc

  • Rescitech Vision Pvt Ltd

  • RetinaPharma Technologies Inc

  • Sapporo Medical University School of Medicine

  • Schott AG

  • Subcuject ApS

  • Sunshine Guojian Pharmaceutical Shanghai Co Ltd

  • Takeda Pharmaceutical Co Ltd

  • TCB medical devices

  • Terumo Corp

  • Teva Pharmaceutical Industries Ltd

  • TheraKine Inc (Inactive)

  • Twin Star Medical Inc

  • Unilife Corporation

  • University of Calgary

  • University of California San Diego

  • University of California San Francisco

  • University of Delaware

  • University of Dundee

  • University of Florida

  • University of New Mexico

  • University of Saskatchewan

  • University of Texas at Austin

  • Vanderbilt University

  • West Pharmaceutical Services Inc

  • Windgap Medical Inc

  • XERIS Pharmaceuticals Inc

  • Ypsomed Holding AG

  • Zosano Pharma Corp

For more information about this report visit https://www.researchandmarkets.com/r/pdw4og

View source version on businesswire.com: https://www.businesswire.com/news/home/20210114005523/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900